These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10589961

  • 1. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients.
    Jamil B, Nicholls K, Becker GJ, Walker RG.
    Transplantation; 1999 Nov 27; 68(10):1597-603. PubMed ID: 10589961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 4. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.
    J Heart Lung Transplant; 1991 Aug 27; 10(6):901-11. PubMed ID: 1661608
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 6. OKT3 for primary therapy of the first rejection episode in kidney transplants.
    Tesi RJ, Elkhammas EA, Henry ML, Ferguson RM.
    Transplantation; 1993 May 27; 55(5):1023-9. PubMed ID: 8497875
    [Abstract] [Full Text] [Related]

  • 7. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 8. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
    Bumgardner GL, Hardie I, Johnson RW, Lin A, Nashan B, Pescovitz MD, Ramos E, Vincenti F, Phase III Daclizumab Study Group.
    Transplantation; 2001 Sep 15; 72(5):839-45. PubMed ID: 11571447
    [Abstract] [Full Text] [Related]

  • 9. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S, Emiroglu R, Karakayali F, Yagmurdur MC, Dalgic A, Moray G, Haberal M.
    Transplant Proc; 2005 Sep 15; 37(7):3016-8. PubMed ID: 16213290
    [Abstract] [Full Text] [Related]

  • 10. The impact of late acute rejection after cadaveric kidney transplantation.
    Joseph JT, Kingsmore DB, Junor BJ, Briggs JD, Mun Woo Y, Jaques BC, Hamilton DN, Jardine AG, Jindal RM.
    Clin Transplant; 2001 Aug 15; 15(4):221-7. PubMed ID: 11683814
    [Abstract] [Full Text] [Related]

  • 11. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH, Lucas BA, Thompson JS, McKeown JW, Brown S, Kryscio R, Skeeters LJ.
    Transplantation; 1997 Jul 27; 64(2):274-81. PubMed ID: 9256187
    [Abstract] [Full Text] [Related]

  • 12. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    Pascual J, Crespo M, Mateos ML, Marcén R, Orofino L, Burgos FJ, Liaño F, Ortuño J.
    Transplant Proc; 1998 Jun 27; 30(4):1329-30. PubMed ID: 9636540
    [No Abstract] [Full Text] [Related]

  • 13. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants.
    Wu JY, Chen JH, Wang YM, He Q, Wu DB.
    Transplantation; 2004 Sep 15; 78(5):713-8. PubMed ID: 15371674
    [Abstract] [Full Text] [Related]

  • 14. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 15; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 15. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 16. Long-term renal function in type I diabetics after kidney or kidney-pancreas transplantation: influence of number, timing, and treatment of acute rejection episodes.
    Hricik DE, Phinney MS, Weigel KA, Knauss TC, Schulak JA.
    Transplantation; 1997 Nov 15; 64(9):1283-8. PubMed ID: 9371669
    [Abstract] [Full Text] [Related]

  • 17. Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.
    Heifets M, Saeed MI, Parikh MH, Sierka D, Kumar MS.
    Drugs Aging; 2004 Nov 15; 21(11):747-56. PubMed ID: 15323580
    [Abstract] [Full Text] [Related]

  • 18. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.
    Lancet; 1997 Oct 25; 350(9086):1193-8. PubMed ID: 9652559
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM, Donadi MO, Oliveira ML, Ponte CN, Pinheiro PM.
    Transplant Proc; 1999 Nov 25; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract] [Full Text] [Related]

  • 20. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.